Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATYR PHARMA, INC.

(LIFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on ATYR PHARMA, INC.
11/11HC Wainwright Adjusts aTyr Pharma's Price Target to $11 from $18, Keeps Buy Rating
MT
10/12ATYR PHARMA : RBC Initiates aTyr Pharma at Outperform, Speculative Risk, Sets Price Target..
MT
09/21ATYR PHARMA : Piper Sandler Starts aTyr Pharma at Overweight With $19 Price Target
MT
09/14ATYR PHARMA : Roth Capital Adjusts aTyr Pharma's Price Target to $21 from $20, Keeps Buy R..
MT
09/14ATYR PHARMA : Oppenheimer Adjusts aTyr Pharma PT to $20 From $14 as ATYR1923 Pulmonary Sar..
MT
09/13ATYR PHARMA : Jones Trading Adjusts Price Target for aTyr Pharma to $20 From $15, Maintain..
MT
09/13ATYR PHARMA : HC Wainwright Adjusts aTyr Pharma PT to $18 From $13, Maintains Buy Rating
MT
05/18ATYR PHARMA : JonesTrading Initiates Coverage on ATyr Pharma With Buy Rating, $15 Price Ta..
MT
05/10ATYR PHARMA : Laidlaw Starts ATyr Pharma at Buy With $18 Price Target
MT
03/24ATYR PHARMA : Oppenheimer Adjusts ATyr Pharma's Price Target to $14 From $12, Keeps Outper..
MT
03/16ATYR PHARMA : Roth Capital Adjusts aTyr Pharma PT to $20 From $15, Maintains Buy Rating
MT
Upcoming event on ATYR PHARMA, INC.